Literature DB >> 9519834

Precipitous clearance of herpes simplex virus antigens from the peripheral nervous systems of experimentally infected C57BL/10 mice.

P Speck1, A Simmons.   

Abstract

Clearance of herpes simplex virus (HSV) from spinal ganglia of experimentally infected mice is known to be dependent on CD8+ T-cells but not on destruction of infected neurons, consistent with a non-cytolytic Tc2 response in the peripheral nervous system. Here, we demonstrate the striking rapidity of such a response in C57BL/10 mice. The number of neurons containing viral DNA and viral antigens increased until 136 h after inoculation of virulent HSV type 1 (strain SC16) into flank skin. Subsequent disappearance of HSV DNA and antigens from infected ganglia was virtually complete only 8 h later. A consistent and unexpected observation was detection of viral antigens in sensory nerve axons for at least 8 h after their disappearance from neuronal somas, raising the intriguing possibility that virus or viral proteins may be transported distally after infection has been terminated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9519834     DOI: 10.1099/0022-1317-79-3-561

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Cell surface expression of H2 antigens on primary sensory neurons in response to acute but not latent herpes simplex virus infection in vivo.

Authors:  R A Pereira; A Simmons
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  A mucosal vaccination approach for herpes simplex virus type 2.

Authors:  Rebecca S Tirabassi; Christopher I Ace; Tatyana Levchenko; Vladimir P Torchilin; Liisa K Selin; Siwei Nie; Dennis L Guberski; Kejian Yang
Journal:  Vaccine       Date:  2010-12-04       Impact factor: 3.641

3.  CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins.

Authors:  D M Koelle; M Schomogyi; C McClurkan; S N Reymond; H B Chen
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Public TCR use by herpes simplex virus-2-specific human CD8 CTLs.

Authors:  Lichun Dong; Penny Li; Tjitske Oenema; Christopher L McClurkan; David M Koelle
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

5.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Importance of NKT cells in resistance to herpes simplex virus, fate of virus-infected neurons, and level of latency in mice.

Authors:  Branka Grubor-Bauk; Jane Louise Arthur; Graham Mayrhofer
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

Review 7.  Recent progress in herpes simplex virus immunobiology and vaccine research.

Authors:  David M Koelle; Lawrence Corey
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

Review 8.  Developments in herpes simplex virus vaccines: old problems and new challenges.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.629

9.  ICP0 antagonizes Stat 1-dependent repression of herpes simplex virus: implications for the regulation of viral latency.

Authors:  William P Halford; Carla Weisend; Jennifer Grace; Mark Soboleski; Daniel J J Carr; John W Balliet; Yumi Imai; Todd P Margolis; Bryan M Gebhardt
Journal:  Virol J       Date:  2006-06-09       Impact factor: 4.099

10.  Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2.

Authors:  William P Halford; Joshua Geltz; Ronald J Messer; Kim J Hasenkrug
Journal:  PLoS One       Date:  2015-12-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.